Global differences in acute heart failure treatment: analysis of the STRONG-HF site feasibility questionnaire.
Maria NovosadovaLauren GianchettiKoji TakagiPriyanka MorishettyLauren GaetaChristopher EdwardsBeth A DavisonAdrien PicodAlexandre MebazaaGad CotterPublished in: ESC heart failure (2023)
In this analysis of feasibility questionnaires, most sites reported general adherence to ESC guidelines for treatment and management of AHF patients although percutaneous and device therapy was less common outside Europe and follow-up after discharge took place late and was not as extensive as recommended. There were wide variations seen within and across regions in some areas.
Keyphrases
- acute heart failure
- end stage renal disease
- chronic kidney disease
- heart failure
- ejection fraction
- type diabetes
- stem cells
- minimally invasive
- peritoneal dialysis
- patient reported outcomes
- patient reported
- metabolic syndrome
- replacement therapy
- mesenchymal stem cells
- skeletal muscle
- insulin resistance
- glycemic control